Prevalence of urinary symptoms and its impact on life quality in patients living with parkinson disease in a mexican population
Objective: To describe the prevalence and the impact on the quality of life in patients living with Parkinson’s disease with urinary symptoms. Background: Parkinson's disease…Extended phenotypes of autosomal recessive cerebellar ataxia type 1: learn from a novel mutation of SYNE1 gene
Objective: Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to cause ARCA type 1 with a remarkable heterogeneity in clinical…Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease
Objective: In this study, we identified specific pattern of cortical atrophy in Parkinson's disease (PD) and investigated whether PD-specific cortical atrophy contributed to motor symptom,…Clinical accuracy of Medtronic’s Percept built in longevity estimate algorithm following device exchange.
Objective: To examine the accuracy of Medtronic’s Percept built in device longevity estimate. Background: In June of 2020 Medtronic received FDA approval for its Percept…Clinical usefulness of tandem gait test for estimating gait and balance in de novo Parkinson’s disease
Objective: The purpose of this study is to objectively evaluate the gait and balance in patients with Parkinson’s disease showing abnormal tandem gait, using three-dimensional motion analysis.…Modeling Parkinson’s disease progression accounting for the effect of symptomatic treatments in the Parkinson’s Progression Markers Initiative study
Objective: To explore the natural history of Parkinson’s disease (PD) accounting for the effect of symptomatic treatments on progression by modeling the time course of…Anle138b-P1-02: A randomised, double-blinded, placebo-controlled phase 1b study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of the oligomer modulator anle138b in Parkinson´s disease
Objective: To present first-in-patient data of the oligomer modulator anle138b (TEV-56286, emrusolmin) in patients with Parkinson’s disease (PD). Background: Synucleinopathies such as PD and Multiple…The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis
Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…Apathy correlated with motor and non-symptoms in de-novo patients with Parkinson’s disease
Objective: We aimed to investigate how the severity of apathy affects motor symptom and other non-motor symptoms in patients with de-novo Parkinson’s disease (PD). Background:…The impact of biographic factors and lifestyle on the symptoms of Parkinson’s Disease – a five year follow-up
Objective: To identify biographic parameters that may have an impact on the different symptoms of parkinson’s disease. Background: Parkinson’s disease (PD) is a neurodegenerative movement…
- « Previous Page
- 1
- …
- 137
- 138
- 139
- 140
- 141
- …
- 186
- Next Page »